Philip A. Gurnev

Also affiliated with Eunice Kennedy Shriver National Institute of Child Health and Human Development

Biochemistry, Genetics and Molecular BiologyEngineeringNeuroscienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Effect of a post-translational modification mimic on protein translocation through a nanopore”.

Effect of a post-translational modification mimic on protein translocation through a nanopore

Nanoscale(2020)10.1039/d0nr01577f

N/A

0.500DataRank · unranked

27 citations

Philip A. Gurnev, Tatiana K. Rostovtseva, Sergey M. Bezrukov, David P. Hoogerheide

Correction to: Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDAC

Cellular and Molecular Life Sciences(2020)10.1007/s00018-019-03417-6

N/A

0DataRank · unranked

1 citations

Philip A. Gurnev, Alexandra Beilina, María Queralt-Martín, William M. Rosencrans, Mark Cookson +3 more

Tunable Electromechanical Nanopore Trap Reveals Populations of Peripheral Membrane Protein Binding Conformations

ACS Nano(2020)10.1021/acsnano.0c07672

N/A

0DataRank · unranked

15 citations

Tatiana K. Rostovtseva, Daniel Jacobs, Philip A. Gurnev, Sergey M. Bezrukov, David P. Hoogerheide

MspA Porin as a Local Nanopore Probe for Membrane-bound Proteins

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.15.464579

N/A

0DataRank · unranked

1 citations

Philip A. Gurnev, Jens H. Gundlach, Andrew H. Laszlo, Tatiana K. Rostovtseva, Sergey M. Bezrukov +1 more

Restricting α-synuclein transport into mitochondria by inhibition of α-synuclein–VDAC complexation as a potential therapeutic target for Parkinson’s disease treatment

Cellular and Molecular Life Sciences(2022)10.1007/s00018-022-04389-w

N/A

0DataRank · unranked

22 citations

María Queralt-Martín, Philip A. Gurnev, William M. Rosencrans, Amandine Rovini, Daniel Jacobs +5 more

Restricting α-Synuclein Transport into Mitochondria by Inhibition of α-Synuclein-VDAC Complexation as a Potential Therapeutic Target for Parkinson’s Disease Treatment

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.07.487541

N/A

0DataRank · unranked

0 citations

María Queralt-Martín, Philip A. Gurnev, William M. Rosencrans, Amandine Rovini, Daniel Jacobs +5 more

Voltage‐activated complexation of α‐synuclein with three diverse β‐barrel channels: VDAC, MspA, and α‐hemolysin

PROTEOMICS(2021)10.1002/pmic.202100060

N/A

0DataRank · unranked

14 citations

Philip A. Gurnev, Tatiana K. Rostovtseva, Sergey M. Bezrukov, David P. Hoogerheide